Literature DB >> 16405999

Lipid composition determines interaction of liposome membranes with Pluronic L61.

Artem E Zhirnov1, Tatiana V Demina, Oxana O Krylova, Irina D Grozdova, Nickolay S Melik-Nubarov.   

Abstract

Triblock copolymers of ethylene oxide (EO) and propylene oxide (PO) of EO(n/2)PO(m)EO(n/2) type (Pluronics) demonstrate a variety of biological effects that are mainly due to their interaction with cell membranes. Previously, we have shown that Pluronics can bind to artificial lipid membranes and enhance accumulation of the anti-tumor drug doxorubicin (DOX) inside the pH-gradient liposomes and transmembrane migration (flip-flop) of NBD-labeled phosphatidylethanolamine in the liposomes composed from one component-lecithin. Here, we describe the effects caused by insertion of other natural lipids in lecithin liposomes and the significance of the lipid composition for interaction of Pluronic L61 with the membrane. We used binary liposomes consisting of lecithin and one of the following lipids: cholesterol, phosphatidylethanolamine, ganglioside GM1, sphingomyelin, cardiolipin or phosphatidic acid. The influence of the additives on (1) membrane microviscosity; (2) binding of Pluronic L61; (3) the copolymer effect on lipid flip-flop and membrane permeability towards DOX was studied. The results showed that insertion of sphingomyelin and cardiolipin did not influence membrane microviscosity and effects of Pluronic on the membrane permeability. Addition of phosphatidic acid led to a decrease in microviscosity of the bilayer and provoked its destabilization by the copolymer. On the contrary, cholesterol increased microviscosity of the membrane and decreased binding of Pluronic and its capacity to enhance flip-flop and DOX accumulation. Analogous tendencies were revealed upon incorporation of egg phosphatidylethanolamine or bovine brain ganglioside GM1. Thus, a reverse dependence between the microviscosity of membranes and their sensitivity to Pluronic effects was demonstrated. The described data may be relevant to mechanisms of Pluronic L61 interaction with normal and tumor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16405999     DOI: 10.1016/j.bbamem.2005.11.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Influence of Cholesterol and Bilayer Curvature on the Interaction of PPO-PEO Block Copolymers with Liposomes.

Authors:  Wenjia Zhang; McKenzie L Coughlin; Joseph M Metzger; Benjamin J Hackel; Frank S Bates; Timothy P Lodge
Journal:  Langmuir       Date:  2019-05-22       Impact factor: 3.882

Review 2.  Polymer genomics: an insight into pharmacology and toxicology of nanomedicines.

Authors:  Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

3.  Formulation and Characterization of Stimuli-Responsive Lecithin-Based Liposome Complexes with Poly(acrylic acid)/Poly(N,N-dimethylaminoethyl methacrylate) and Pluronic® Copolymers for Controlled Drug Delivery.

Authors:  Mónica G Simões; Ayelen Hugo; Andrea Gómez-Zavaglia; Pedro N Simões; Patrícia Alves
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

4.  Formulation and characterization of echogenic lipid-Pluronic nanobubbles.

Authors:  Tianyi M Krupka; Luis Solorio; Robin E Wilson; Hanping Wu; Nami Azar; Agata A Exner
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

Review 5.  Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.

Authors:  Chiranjeevi Peetla; Andrew Stine; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

6.  Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.

Authors:  Stefanie Wohlfart; Alexander S Khalansky; Svetlana Gelperina; Olga Maksimenko; Christian Bernreuther; Markus Glatzel; Jörg Kreuter
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

Review 7.  Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.

Authors:  Kanawat Wiwatchaitawee; Juliana C Quarterman; Sean M Geary; Aliasger K Salem
Journal:  AAPS PharmSciTech       Date:  2021-02-11       Impact factor: 4.026

Review 8.  Pluronics and MDR reversal: an update.

Authors:  Daria Y Alakhova; Alexander V Kabanov
Journal:  Mol Pharm       Date:  2014-07-10       Impact factor: 4.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.